# DEVELOPMENT&MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/1

> **NIH NIH N01** · MURTY PHARMACEUTICALS, INC. · 2020 · $97,575

## Abstract

To carry out the development and manufacture of pharmaceutical preparations to be used in the medications development program of the National Institute on Drug Abuse (NIDA) for treating substance use disorders.

## Key facts

- **NIH application ID:** 10285052
- **Project number:** 271201600028C-P00009-9999-4
- **Recipient organization:** MURTY PHARMACEUTICALS, INC.
- **Principal Investigator:** RAM MURTY
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $97,575
- **Award type:** —
- **Project period:** 2016-09-18 → 2021-09-17

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10285052

## Citation

> US National Institutes of Health, RePORTER application 10285052, DEVELOPMENT&MANUFACTURE OF PHARMACEUTICAL PRODUCTS FOR THE TREATMENT OF SUBSTANCE ABUSE DISORDERS. NIDA REF. NO. N01DA-16-8926; POP: 09/18/2016 - 09/1 (271201600028C-P00009-9999-4). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10285052. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*